Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 11;24(1):2778.
doi: 10.1186/s12889-024-20267-5.

Effects of single and combined urinary polycyclic aromatic hydrocarbon effects on lung function in the U.S. adult population

Affiliations

Effects of single and combined urinary polycyclic aromatic hydrocarbon effects on lung function in the U.S. adult population

Pu Fang et al. BMC Public Health. .

Abstract

Background: The impact of polycyclic aromatic hydrocarbons (PAHs) on lung function has garnered attention, but studies mostly focus on individual effect. This study investigates urinary PAH metabolites as biomarkers of exposure and assesses the relationships between single and combined exposures to nine urinary PAH metabolites and lung function in adults.

Methods: Data from 4040 adults in the 2007-2012 National Health and Nutrition Examination Survey (NHANES) were analyzed. Weighted generalized linear models estimated the effects of individual PAH metabolites on lung function. Additionally, weighted quantile sum (WQS) regression, quantile g-computation (qgcomp), and Bayesian kernel machine regression (BKMR) were employed to evaluate the combined impacts of multiple PAH metabolites.

Results: Analyses of individual PAH metabolites revealed negative associations with lung function, excluding forced vital capacity (FVC). The WQS, qgcomp, and BKMR models consistently showed that exposure to multiple PAH metabolites was associated with lung function decrease. WQS indicated that 2-hydroxynaphthalene (2-NAP) was the largest contributor to the reductions in forced expiratory volume in 1 s (FEV1), FVC, peak expiratory flow (PEF), and forced expiratory flow from 25 to 75% of FVC (PEF25-75%). Additionally, 1-hydroxypyrene (1-PYR) was the primary PAH metabolite contributing to the decreases in FEV1/FVC and fractional exhaled nitric oxide (FeNO). The combined effect of urinary PAH metabolites did not affect FVC in the current smokers or FeNO in nonsmokers, but decreased FEV1/FVC in current smokers.

Conclusion: This study strengthens the negative relationships between multiple PAH metabolites exposure and lung function in adults. Given the limitations of this study, including the lack of knowledge of other exposure pathways and the uncertainty of urinary metabolites, further research is necessary to explore the mechanisms underlying these associations and to address the limitations in exposure assessment.

Keywords: Combined effect; Lung function; NHANES; Polycyclic aromatic hydrocarbon.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Weighted values of OH-PAHs for FEV1 (A), FVC (B), FEV1/FVC (C), PEF (D), PEF25 − 75% (E) and FeNO (F) in the WQS model. Notes: Adjusted for gender, age, ethnicity, education level, FIR, marital status, serum cotinine, drinking, BMI, hypertension, and diabetes mellitus
Fig. 2
Fig. 2
The estimated risk of the combined effect of OH-PAHs co-exposure on FEV1 (A), FVC (B), FEV1/FVC (C), PEF (D), PEF25 − 75% (E) and FeNO (F) by BKMR. Notes: Adjusted for gender, age, ethnicity, education level, FIR, marital status, serum cotinine, drinking, BMI, hypertension, and diabetes mellitus
Fig. 3
Fig. 3
The weights of the positive and negative factors for FEV1 (A), FVC (B), FEV1/FVC (C), PEF (D), PEF25 − 75% (E) and FeNO (F) in the qgcomp model. Notes: Adjusted for gender, age, ethnicity, education level, FIR, marital status, serum cotinine, drinking, BMI, hypertension, and diabetes mellitus

References

    1. Kim KH, Jahan SA, Kabir E, Brown RJ. A review of airborne polycyclic aromatic hydrocarbons (PAHs) and their human health effects. Environ Int. 2013;60:71–80. 10.1016/j.envint.2013.07.019. - PubMed
    1. Zhao X, Gao J, Zhai L, Yu X, Xiao Y. Recent evidence on polycyclic aromatic hydrocarbon exposure. Healthc (Basel). 2023;11(13):1958. 10.3390/healthcare11131958. - PMC - PubMed
    1. Beyer J, Jonsson G, Porte C, Krahn MM, Ariese F. Analytical methods for determining metabolites of polycyclic aromatic hydrocarbon (PAH) pollutants in fish bile: a review. Environ Toxicol Pharmacol. 2010;30(3):224–44. 10.1016/j.etap.2010.08.004. - PubMed
    1. Motorykin O, Santiago-Delgado L, Rohlman D, Schrlau JE, Harper B, Harris S, et al. Metabolism and excretion rates of parent and hydroxy-PAHs in urine collected after consumption of traditionally smoked salmon for native American volunteers. Sci Total Environ. 2015;514:170–7. 10.1016/j.scitotenv.2015.01.083. - PMC - PubMed
    1. Yu H. Environmental carcinogenic polycyclic aromatic hydrocarbons: photochemistry and phototoxicity. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2002;20(2):149–83. 10.1081/GNC-120016203. - PMC - PubMed

Publication types

Substances

LinkOut - more resources